Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 02:30 am EDT
Share
Ever Fortune.AI Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 15.94 million compared to TWD 14.5 million a year ago. Net loss was TWD 0.93 million compared to TWD 11.92 million a year ago. Basic loss per share from continuing operations was TWD 0.01 compared to TWD 0.13 a year ago. Diluted loss per share from continuing operations was TWD 0.01 compared to TWD 0.13 a year ago.
For the six months, sales was TWD 27.89 million compared to TWD 23.33 million a year ago. Net income was TWD 1.55 million compared to net loss of TWD 28.35 million a year ago. Basic earnings per share from continuing operations was TWD 0.02 compared to basic loss per share from continuing operations of TWD 0.32 a year ago. Diluted earnings per share from continuing operations was TWD 0.02 compared to diluted loss per share from continuing operations of TWD 0.32 a year ago.
Ever Fortune. AI Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical artificial intelligence software related products. The Company mainly provides medical big data and cloud biomedical platform, medical artificial intelligence (AI) technology solutions. The Company provides medical artificial intelligence data, analysis technology and services, and customized medical AI technology solutions. The Company's products include radiographic bone age-assisted interpretation and height prediction system, ultrasound breast tumor auxiliary classification system, computer tomography liver cancer metastasis risk management system, liver fibrosis evaluation system, and irregular cardiac fibrillation interpretation.